Physician profile
Donna Ford
NPI 1609064054
$1,762.13
in general payments reported to CMS, 2019-2025
20 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $202 · 2023: $349 · 2024: $525 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $412.90 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $294.11 | 2023-2025 | Sotyktu |
| Leo Pharma INC. | $210.26 | 2021-2024 | Adbry |
| Galderma Laboratories, L.P. | $154.84 | 2023-2025 | Nemluvio |
| Incyte Corporation | $106.99 | 2021-2025 | Opzelura |
| Genzyme Corporation | $86.68 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $74.40 | 2023-2025 | Ilumya |
| Pfizer INC. | $66.95 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $61.54 | 2024-2025 | |
| Averitas Pharma INC. | $54.32 | 2025 | Qutenza |
| Janssen Biotech, INC. | $46.05 | 2025 | Tremfya |
| Amgen INC. | $33.61 | 2024 | Otezla |
| Lilly USA, LLC | $30.19 | 2025 | Taltz, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.75 | 2024 | Cabtreo |
| Journey Medical Corporation | $21.94 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $20.03 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $19.08 | 2024 | Zoryve |
| Orapharma, A Division of Bausch Health US, LLC | $16.93 | 2025 | Ossix Plus, Arestin |
| Dermavant Sciences, INC. | $14.77 | 2024 | Vtama |
| Heron Therapeutics, INC. | $12.79 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.